RESUMO

Hepatitis C virus (HCV) genotype 5 is extremely rare and there is very little reported on its management in the medical literature. We present herein the case of a patient with HCV genotype 5 that presumably acquired the disease through a blood transfusion during infancy. Sustained virologic response was achieved after 24 weeks of treatment. According to the available information on HCV genotype 5 treatment, it has a similar response to that of HCV genotype 1. Our patient presented with various favorable outcome factors. There is much less reported on the treatment of HCV genotype 5 than there is regarding HCV genotypes 1, 2, 3, and 4. This is mainly due to the low prevalence of genotype 5 in the Mexican environment.

Assuntos

Hepacivirus/genética , Hepatite C/terapia , Hepatite C/virologia , Adulto , Antivirais/uso terapêutico , Genótipo , Hepatite C/epidemiologia , Humanos , Interferon-alfa/uso terapêutico , Masculino , México/epidemiologia , Ribavirina/uso terapêutico , Resultado do Tratamento